Sunrise International Labs is a pharmaceutical company wholly owned by Perdaman Pharmaceuticals, a leading and well-established, international pharmaceutical manufacturing and exporting company based in New Delhi, India.

Located in Cherlapally, Hyderabad in India, Sunrise International Labs is a WHO/cGMP certified facility. It also has an approved facility in Ethiopia (EFMHACA), and an approved facility in the Ivory Coast (DPM). Sunrise International Labs’ manufacturing facilities are also approved by reputed agencies in a variety of other countries across the globe including Senegal, Uganda, Sri Lanka and Cambodia.

India hosts a multitude of impressive manufacturing plants. The country is among the top 20 pharmaceutical exporters worldwide, and ranks as one of the highest countries in the world relating to cost efficiency.

An established and well-recognised company since 1986, Sunrise International Lab’s reputation heralds from its expertise in drug delivery systems, along with its therapeutic division.

Its premises are amongst the largest at 100,000-square feet with inhouse testing performed, as well as housing a water treatment plant, and well-equipped quality control, manufacturing, administration and storage areas.

The Sunrise International Labs vision has always been to supply affordable and quality product formulations to every remote corner of the globe. With Perdaman Pharmaceuticals now at its helm, the company’s growth is assured, and Perdaman Pharmaceuticals with the acquisition of Sunrise International Labs, strengthens its position in the pharmaceutical world.

We welcome mutually beneficial partnership discussions.